
Pharma’s US$150bn investment in US sparks ‘exodus’ fears
PHARMACEUTICAL companies have invested more than US$150bn in US manufacturing and R&D since the election of Donald Trump, triggering lobbying for legislative intervention to prevent an “exodus” from Europe. Swiss company Roche is the latest to announce …